AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 275: H1567-H1576, 1998;
0363-6135/98 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Holmuhamedov, E. L.
Right arrow Articles by Terzic, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Holmuhamedov, E. L.
Right arrow Articles by Terzic, A.
Vol. 275, Issue 5, H1567-H1576, November 1998

Mitochondrial ATP-sensitive K+ channels modulate cardiac mitochondrial function

Ekshon L. Holmuhamedov, Sofija Jovanovic', Petras P. Dzeja, Aleksandar Jovanovic', and Andre Terzic

Division of Cardiovascular Diseases, Department of Medicine and Pharmacology, Mayo Clinic, Mayo Foundation, Rochester, Minnesota 55905

    ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Discovered in the cardiac sarcolemma, ATP-sensitive K+ (KATP) channels have more recently also been identified within the inner mitochondrial membrane. Yet the consequences of mitochondrial KATP channel activation on mitochondrial function remain partially documented. Therefore, we isolated mitochondria from rat hearts and used K+ channel openers to examine the effect of mitochondrial KATP channel opening on mitochondrial membrane potential, respiration, ATP generation, Ca2+ transport, and matrix volume. From a mitochondrial membrane potential of -180 ± 15 mV, K+ channel openers, pinacidil (100 µM), cromakalim (25 µM), and levcromakalim (20 µM), induced membrane depolarization by 10 ± 7, 25 ± 9, and 24 ± 10 mV, respectively. This effect was abolished by removal of extramitochondrial K+ or application of a KATP channel blocker. K+ channel opener-induced membrane depolarization was associated with an increase in the rate of mitochondrial respiration and a decrease in the rate of mitochondrial ATP synthesis. Furthermore, treatment with a K+ channel opener released Ca2+ from mitochondria preloaded with Ca2+, an effect also dependent on extramitochondrial K+ concentration and sensitive to KATP channel blockade. In addition, K+ channel openers, cromakalim and pinacidil, increased matrix volume and released mitochondrial proteins, cytochrome c and adenylate kinase. Thus, in isolated cardiac mitochondria, KATP channel openers depolarized the membrane, accelerated respiration, slowed ATP production, released accumulated Ca2+, produced swelling, and stimulated efflux of intermembrane proteins. These observations provide direct evidence for a role of mitochondrial KATP channels in regulating functions vital for the cardiac mitochondria.

heart; mitochondria; potassium channel openers; calcium

    INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

THE POTASSIUM ION is the major cytoplasmic and mitochondrial cation, and net flux of K+ across the inner mitochondrial membrane critically regulates mitochondrial activity (16). This includes regulation of energy production and maintenance of cellular Ca2+ homeostasis, two mitochondrial functions essential for cellular survival (12, 15, 23, 24). To allow for bidirectional K+ cycling across an otherwise K+-impermeable inner membrane, mitochondria express specialized K+ conduits (16). These include the well-characterized electroneutral K+/H+ antiporter responsible for K+ efflux, along with less known pathways for K+ influx (8, 15).

A candidate mechanism for K+ entry is an ATP-sensitive K+ (KATP) channel (15, 16). This channel, known as the mitochondrial KATP channel, has been recently identified within the inner mitochondrial membrane (29), and the molecular identity of channel subunits has been partially characterized (16, 59, 60). Purified channel proteins, when incorporated into artificial bilayers or liposomes, reconstitute an ATP-sensitive K+ conductance with properties similar to those previously described for other members of the KATP channel family (52). This channel family regroups nucleotide-gated inwardly rectifying K+ channels, which sense the metabolic state of a cell and regulate K+ flux and membrane excitability (1, 2, 31, 42, 46, 59, 67).

KATP channels have been originally described in the cardiac sarcolemma (50), and opening of sarcolemmal KATP channels has been associated with shortening of cardiac action potential, decrease in intracellular Ca2+ loading, and cardioprotection during ischemia (5, 14, 20, 21, 32, 33, 44). However, the consequences of activation of mitochondrial KATP channels on mitochondrial functions, including oxidative phosphorylation and Ca2+ transport, have not been determined.

K+ channel-opening drugs are the established tool used to activate KATP channels (21, 54, 66) and also target the mitochondrial KATP channels (17, 18, 61, 62). Therefore, in this study we used K+ channel openers to examine the effect of mitochondrial KATP channel opening on mitochondrial functions, including membrane potential, respiration, ATP generation, Ca2+ transport, and membrane integrity. We present evidence that activation of mitochondrial KATP channels modulates the function of isolated cardiac mitochondria.

    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Isolated cardiac mitochondria. Cardiac mitochondria were isolated from ether- or pentobarbital-anesthetized rats by differential centrifugation (25, 43). After thoracotomy, hearts were rapidly excised into an ice-cold isolation buffer (50 mM sucrose, 200 mM mannitol, 5 mM KH2PO4, 1 mM EGTA, 5 mM MOPS, and 0.1% BSA, pH 7.15 adjusted with KOH), atria were removed, and 1-mm3 pieces of ventricular myocardium were homogenized (30 ml of isolation buffer per heart) using a PT10/35 Polytron (Brinkman). Three 20-s homogenization cycles were performed on ice, and then the samples were centrifuged for 10 min (at 750 g) using a Sorvall II centrifuge equipped with a GSA rotor. The supernatant, containing the mitochondrial fraction, was further centrifuged at 7,000 g for 20 min, and the pellet was resuspended in 30 ml of isolation buffer (with no EGTA) and spun at 7,000 g for 20 min. Finally, mitochondria were resuspended in the isolation buffer (with no EGTA), and protein concentration was determined using a protein kit (Bio-Rad). Mitochondrial suspension (~30-40 mg protein/ml) was kept on ice before experiments.

Mitochondrial membrane potential. Measurements were made at 30°C under continuous stirring of the mitochondrial suspension (1 mg protein/ml incubation medium) placed into a multichannel chamber of an ESON-6ch computerized analyzer (25-28). The standard incubation medium contained (in mM) 110 KCl, 5 K2HPO4, 5 succinate, 5 pyruvate, and 10 MOPS (pH 7.15). Mitochondrial membrane potential was measured with tetraphenylphosphonium (TPP+)-sensitive minielectrodes manufactured and calibrated as described elsewhere (38). TPP+ (200 nM) was added to the incubation medium in the chamber before addition of mitochondria, and mitochondrial membrane potential was calculated according to the following equation: Delta Psi  = 59 × log (v/V) - 59 × log [10(E - E0)/59 - 1], where Delta Psi is mitochondrial membrane potential (mV), v is mitochondrial matrix volume (1.6 µl/mg mitochondrial protein) (53), V is volume of incubation medium (1 ml), and E0 and E are electrode potentials before and after addition of mitochondria, respectively (49). Membrane potential was measured in the presence of K+ channel openers [pinacidil (RBI), cromakalim (Sigma Chemical), and levcromakalim (a gift from SmithKline Beecham)], K+ ionophore (valinomycin), and/or K+ channel blockers [glyburide and 5-hydroxydecanoic acid (5-HD), both from RBI]. In addition, mitochondrial membrane potential was also measured after addition of ADP, in the absence and presence of a K+ channel opener.

Mitochondrial respiration. O2 consumption of mitochondria was measured in the multichannel chamber using a calibrated Clark-type O2 minielectrode (11, 25). For calibration purposes, depletion of O2 content within the mitochondrial suspension was achieved by sodium hydrosulfite. Data acquisition and processing were the same as with the TPP+ electrode. The effects of drugs were assessed on "state 2" mitochondrial respiration (7). In addition, in certain experiments, ADP-stimulated mitochondrial respiration ("state 3") was measured in the absence and presence of a K+ channel opener.

Mitochondrial Ca2+ uptake. Mitochondrial Ca2+ uptake was measured as a change in the free Ca2+ concentration within the suspension using calibrated Ca2+-selective minielectrodes (Microelectrodes) (11, 26, 28). Data acquisition and processing were the same as with the TPP+ electrode. The effect of K+ channel openers on mitochondrial Ca2+ retention and release was studied in mitochondria preloaded with Ca2+ (3 consecutive 40-nmol Ca2+ pulses/mg mitochondrial protein).

Mitochondrial ATP synthesis. Mitochondrial ATP content was determined in mitochondrial extracts (9). Briefly, 200 µl of mitochondrial suspension were treated with 20 µl of 3.3 M HClO4, and precipitated proteins were removed by centrifugation (60 s, 14,000 rpm, 4°C). After neutralization of the supernatant with 80 µl of a mixture containing 2.5 M K2CO3 in 1 M HEPES, the precipitate was separated by centrifugation (60 s, 14,000 rpm, 4°C), and the concentration of ATP within the extract was determined by coupled enzymatic analysis based on spectrophotometric detection of NADH (40) in the absence and presence of a K+ channel opener.

Mitochondrial volume and integrity. Light scattering of mitochondrial suspensions, a measure of matrix volume (18, 24, 25), was determined within a 10-mm cuvette (maintained at 22°C) in the presence of K+ channel openers or a K+ ionophore. The absorbance of the mitochondrial suspension was measured at 540 nm using a spectrophotometer (model DU-7400, Beckman).

The integrity of the mitochondrial membrane, in the absence and presence of K+ channel openers, was assessed by measuring release of cytochrome c and adenylate kinase, two intermembrane proteins (47, 56). Supernatants, obtained after sedimentation (at 14,000 g, 15 min, 4°C) of the mitochondrial suspension, were concentrated by ultrafiltration (Centricon 3, Amicon), and an aliquot (30 µl) was immobilized on nitrocellulose membranes (Optitran BA-NC) using a Minifold I dot-blot system. Membrane dot blots were probed with a mouse anti-cytochrome c monoclonal antibody (clone 6H2.B4, Pharmingen) and detected with a rabbit anti-mouse IgG conjugated with horseradish peroxidase (Amersham), which served as a secondary antibody. The blot was placed on the SuperSignal CL-HRP substrate (Pierce) and exposed to an X-Omat film (Eastman Kodak) for 60 s. Adenylate kinase activity was determined within the supernatant spectrophotometrically (9, 10, 40).

    RESULTS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Effect on mitochondrial membrane potential. Isolated cardiac mitochondria had a membrane potential of -180 ± 15 mV (n = 12), as demonstrated using a potential-sensitive probe, TPP+ (Fig. 1A). Mitochondria maintained a steady membrane potential throughout the duration of recordings (up to 40 min). Addition of the K+ channel opener pinacidil (100 µM) induced rapid depolarization (Fig. 1A). On average, mitochondrial membrane potential decreased by 10 ± 7 mV (n = 5) in the presence of 100 µM pinacidil. The effect of pinacidil was concentration dependent (Fig. 1B). The K+ ionophore valinomycin (12.5 ng/mg mitochondrial protein) also reduced mitochondrial membrane potential, indicating that depolarization can be triggered by promoting K+ flux across the mitochondrial membrane (Fig. 1A).


View larger version (10K):
[in this window]
[in a new window]
 
Fig. 1.   Effect of pinacidil (PIN) on mitochondrial membrane potential. Mitochondrial membrane potential was measured using the membrane potential-sensitive probe tetraphenylphosphonium (TPP+). Arrowhead, addition of isolated cardiac mitochondria to a solution containing TPP+. On addition of mitochondrial suspension, resting membrane potential was rapidly achieved. A: pinacidil (100 µM)-induced membrane depolarization. K+ ionophore valinomycin (Valino, 12.5 ng/mg mitochondrial protein) was added as a positive control. B: concentration-response curve for effect of pinacidil on mitochondrial membrane potential. Values are means ± SE of 3-5 measurements.

Cromakalim (Fig. 2A) and levcromakalim (Fig. 3A), K+ channel openers that are structurally unrelated to pinacidil, also induced mitochondrial membrane depolarization when applied at concentrations known to activate plasmalemmal KATP channels (21, 65). On average, cromakalim (25 µM) and levcromakalim (20 µM) decreased the mitochondrial membrane potential by 25 ± 9 and 24 ± 10 mV, respectively (n = 4).


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 2.   Cromakalim (CROM)-induced mitochondrial membrane depolarization and extramitochondrial concentration of K+. A: cromakalim (20 µM)-induced membrane depolarization. Valinomycin (12.5 ng/mg mitochondrial protein) was added as a positive control. B: in nominally K+-free solution (i.e., KCl replaced with 110 mM choline chloride, K2HPO4 with 5 mM Na2HPO4, and pH adjusted with Trizma base), cromakalim (20 µM) was without effect. Addition of KCl (in 4 mM steps) restored the depolarizing effect of cromakalim. C: in deenergized mitochondria treated with antimycin A (AntiA, 1 µg/mg mitochondrial protein) and oligomycin (Oligo, 1 µg/mg mitochondrial protein), cromakalim (in 25 µM steps) induced mitochondrial membrane hyperpolarization in nominally K+-free solution. Arrowheads, addition of isolated cardiac mitochondria to a solution containing TPP+. Mitochondrial membrane potential was measured as described in Fig. 1 legend.


View larger version (7K):
[in this window]
[in a new window]
 
Fig. 3.   Levcromakalim (LEV)-induced mitochondrial membrane depolarization and a blocker of ATP-sensitive K+ (KATP) channels. A: levcromakalim (25 µM)-induced membrane depolarization. Valinomycin (12.5 ng/mg mitochondrial protein) was added as a positive control. B: in mitochondria treated with KATP channel blocker 5-hydroxydecanoic acid (5-HD, 20 µM), levcromakalim (20 µM) did not induce membrane depolarization. Arrowheads, addition of isolated cardiac mitochondria to a solution containing TPP+. Mitochondrial membrane potential was measured as described in Fig. 1 legend.

In nominally K+-free medium, cromakalim could no longer induce mitochondrial depolarization (Fig. 2B). Introduction of KCl into the medium bathing mitochondria restored the depolarizing effect of cromakalim (Fig. 2B). Conversely, in mitochondria in which the potential was dissipated by antimycin A (an inhibitor of the mitochondrial respiratory chain) and oligomycin (an inhibitor of mitochondrial ATPase), cromakalim, in the absence of extramitochondrial K+, induced hyperpolarization of the mitochondrial membrane (Fig. 2C). This suggests that the effect of the K+ channel opener on mitochondrial membrane potential is dependent on the electrochemical gradient for K+.

The depolarizing effect of K+ channel openers was sensitive to 5-HD, a selective antagonist of KATP channels (51). By itself, 5-HD (20 µM) had no effect on the steady-state mitochondrial membrane potential but prevented mitochondrial depolarization by levcromakalim (20 µM; Fig. 3; n = 7).

ADP, a mitochondrial substrate used in the production of ATP, is known to induce transient mitochondrial depolarization, the duration of which depends on the time required for conversion of ADP to ATP (43). In the absence of a K+ channel opener, ADP (500 µM) induced depolarization of cardiac mitochondria that lasted 105 ± 15 s (Fig. 4A; n = 6). In the presence of pinacidil (100 µM-1 mM), the ADP-induced mitochondrial membrane depolarization was significantly prolonged (Fig. 4).


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 4.   Effect of pinacidil on ADP-induced mitochondrial membrane depolarization. A: ADP (500 µM)-induced mitochondrial membrane depolarization in absence (Control) and presence of pinacidil (100 µM). B: concentration-response curve for effect of pinacidil on duration of ADP (500 µM)-induced membrane depolarization. Values are means ± SE.

Effect on mitochondrial respiration. The rate of state 2 respiration of isolated cardiac mitochondria was 14.0 ± 1.3 nmol O2 · min-1 · mg protein-1 (n = 20). Pinacidil (100 µM-1 mM), in a concentration-dependent manner, induced an increase in the rate of mitochondrial respiration (Fig. 5A). Pretreatment (3-5 min) of mitochondria with the KATP channel blocker glyburide (1 µM) inhibited the effect of pinacidil on mitochondrial respiration (Fig. 5B; n = 3).


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 5.   Effect of pinacidil on mitochondrial O2 consumption. A: concentration-response curve for effect of pinacidil on O2 consumption. Values are means ± SE. B: glyburide (1 µM) inhibits 100 µM pinacidil-induced increase in mitochondrial O2 consumption. Values are means ± SE. * Significant difference (P < 0.01, Student's t-test) between absence and presence of glyburide.

ADP (500 µM) induced transition of mitochondria from state 2 to state 3 respiration (Fig. 6; n = 6). Pinacidil (100 µM) slowed ADP-induced state 3 respiration (from 165 ± 7 to 55 ± 5 natoms O2 · min-1 · mg protein-1 in the absence and presence of pinacidil, respectively) without changing the total amount of the ADP-stimulated O2 consumption, which was 340 ± 10 and 353 ± 8 natoms in the absence and presence of the K+ channel opener (n = 3; Fig. 6).


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 6.   Effect of pinacidil on ADP-induced acceleration of mitochondrial respiration. Mitochondrial rate of respiration was measured using an O2-sensing electrode in pinacidil-untreated (A) and pinacidil (100 µM)-treated (B) mitochondria under control conditions (V2 vs. V'2) and in presence of ADP (V3 and V4 vs. V'3 and V'4). Delta t, Time mitochondria spent in ADP-induced state 3 respiration; Delta O2, magnitude of ADP-induced O2 consumption. Mitochondrial uncoupler dinitrophenol (DNP, 40 µM) was added at end of each experiment to verify mitochondrial responsiveness. Arrowheads, addition of isolated cardiac mitochondria.

Effect on mitochondrial ATP synthesis. Isolated cardiac mitochondria efficiently phosphorylated ADP (500 µM) so that ~90% of added ADP was converted to ATP within 100 ± 15 s (n = 3; Fig. 7). The initial rate of ATP synthesis was 401 ± 35 nmol ATP · min-1 · mg protein-1, and the half-time required for complete conversion of added ADP to ATP was 27 ± 5 s (n = 3; Fig. 7). Pinacidil (100 µM) decreased the rate of initial ATP synthesis to 187 ± 23 nmol ATP · min-1 · mg protein-1 and increased the half-time required for conversion of ADP to ATP to 87 ± 7 s (n = 3; Fig. 7). Although the rate of mitochondrial synthesis was slowed, pinacidil (100 µM) did not prevent conversion of ADP to ATP (Fig. 7).


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 7.   Effect of pinacidil on mitochondrial conversion of ADP to ATP. Time course of ATP synthesis after addition of 500 µM ADP was measured in absence and presence of 100 µM pinacidil. Values are means ± SE. [ATP], ATP concentration.

Effect on mitochondrial Ca2+ loading. Mitochondria are known to accumulate and to retain Ca2+ within the matrix (22). Isolated cardiac mitochondria efficiently took up and retained added Ca2+ when repeatedly challenged with extramitochondrial Ca2+ pulses (in total 120 nmol Ca2+/mg mitochondrial protein; Fig. 8). Addition of pinacidil (250 µM) induced rapid release of Ca2+ from preloaded mitochondria (Fig. 8, A-C). The efficacy of pinacidil to induce release of mitochondrial Ca2+ was dependent on the extramitochondrial concentration of K+ (Fig. 8, A-C). At 1, 10, and 110 mM extramitochondrial KCl, the magnitude of pinacidil-induced Ca2+ release was 1, 3, and 5 nmol Ca2+/mg mitochondrial protein, respectively (Fig. 8, A-C). The Ca2+-releasing effect of pinacidil (250 µM) was suppressed by pretreatment of mitochondria with the KATP channel blocker glyburide (1 µM; Fig. 8D).


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 8.   Effect of pinacidil on Ca2+ release from mitochondria. Original records of extramitochondrial Ca2+ concentration measured using a Ca2+-sensitive electrode are shown. Arrowheads, addition of mitochondrial suspension. Ca2+ was added as a series of 3 pulses (40 nmol each) to load mitochondria. A-C: pinacidil (100 µM)-induced release of Ca2+ from mitochondria. Magnitude of pinacidil-induced Ca2+ release was dependent on concentration of extramitochondrial K+ (i.e., 1, 10, and 110 mM). Treatment with glyburide (GLYB, 1 µM) suppressed pinacidil (100 µM) to induce release of mitochondrial Ca2+. In D, valinomycin (12.5 ng/mg mitochondrial protein) was added as a positive control.

Effect on mitochondrial matrix volume and integrity. The volume of mitochondria depends on the permeability of the inner membrane to osmotically active particles, such as K+ (6). The K+ channel opener cromakalim (100 µM) induced swelling of mitochondria, as revealed by a decrease in the absorbance of the mitochondrial suspension in K+-containing media by 0.1 ± 0.02 optical density unit (n = 3; Fig. 9A). Under this condition, the K+ ionophore valinomycin also induced significant mitochondrial swelling (not shown). In contrast, in K+-free medium, cromakalim had no significant effect on mitochondrial swelling (Fig. 9; n = 3). K+-dependent changes in mitochondrial volume were also observed with pinacidil (250 µM; Fig. 9B).


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 9.   Effect of K+ channel openers on mitochondrial matrix volume. A: original records of mitochondrial volume expressed as optical density (OD) of mitochondrial suspension in K+-free (sucrose: KCl was isotonically replaced with 220 mM sucrose and K2HPO4 with 5 mM Na2HPO4, and pH was adjusted with Trizma base) or K+-containing standard incubation medium (KCl). Arrows, addition of cromakalim (25 µM). B: average effect of K+ channel openers, 25 µM cromakalim and 100 µM pinacidil, on mitochondrial volume. Values are means ± SE. * Significantly different (P < 0.01, Student's t-test) from sucrose.

Cytochrome c and adenylate kinase are located within the intermembrane space of mitochondria (58). Under control conditions, isolated cardiac mitochondria show no significant release of cytochrome c (Fig. 10) or adenylate kinase (Fig. 11). KATP channel openers pinacidil (250 µM) and cromakalim (100 µM) induced release of cytochrome c (Fig. 10) and adenylate kinase (Fig. 11). The K+ ionophore valinomycin (12.5 ng/mg mitochondrial protein), used as a positive control, also induced release of cytochrome c (Fig. 10) and adenylate kinase (Fig. 11).


View larger version (42K):
[in this window]
[in a new window]
 
Fig. 10.   Effect of K+ channel openers on cytochrome c release from mitochondria. Dot blots of extramitochondrial medium were obtained using a monoclonal anti-cytochrome c antibody (Ab) under control conditions and after treatment of mitochondria with K+ channel openers, pinacidil (250 µM) and cromakalim (100 µM). Valinomycin (56 ng/mg mitochondrial protein) was used as a positive control.


View larger version (36K):
[in this window]
[in a new window]
 
Fig. 11.   Effect of K+ channel openers on adenylate kinase release from mitochondria. Adenylate kinase activity was measured under control conditions and after treatment of mitochondria with K+ channel openers, pinacidil (250 µM) and cromakalim (100 µM). Valinomycin (56 ng/mg of mitochondrial protein) was used as a positive control.

    DISCUSSION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

In the present study we report that, in mitochondria isolated from cardiac muscle, K+ channel openers induced membrane depolarization, accelerated respiration, slowed ATP production, triggered release of Ca2+, and produced swelling associated with efflux of intermembrane proteins. In accord with an activation of mitochondrial KATP channels, these effects were dependent on the extramitochondrial concentration of K+, were inhibited by blockers of KATP channels, and could be induced by structurally distinct K+ channel openers. These observations provide direct evidence for a role of mitochondrial KATP channels in the regulation of mitochondrial functions.

That KATP channels are present within the inner membrane of mitochondria was initially demonstrated on the basis of electrophysiological measurements of a K+-selective, ATP-gated ion conductance in fused giant mitoplasts (29). The presence of functional KATP channels in mitochondria was confirmed after isolation of an inner membrane protein fraction from rat liver and beef heart mitochondria, which, when reconstituted in liposomes or planar lipid bilayers, catalyzed electrophoretic ATP-sensitive K+ flux (52). This ATP-inhibited K+ flux was activated by K+ channel openers such as cromakalim (18) and suppressed by K+ channel blockers such as glyburide and 5-HD (3, 17, 51, 63). K+ influx through this channel was hypothesized to serve as a mechanism for osmotic regulation of mitochondrial volume (15, 23, 29, 62). In mitochondria from noncardiac tissue, such as liver and pancreatic beta -cells, openers of KATP channels were found to affect mitochondrial energy metabolism (16, 19, 63). Thus the present findings that opening of mitochondrial KATP channels can modulate multiple functions in isolated cardiac mitochondria provide direct evidence for a KATP channel-mediated regulation of cardiac mitochondrial behavior.

Pinacidil, cromakalim, and levcromakalim share the property to activate KATP channels (21, 54, 66) and were found here to depolarize the membrane potential of cardiac mitochondria. However, it has remained controversial whether opening of mitochondrial KATP channels can be associated with changes in mitochondrial membrane potential (19, 61). In pancreatic beta -cells, glyburide, a KATP channel blocker, failed to antagonize the depolarizing effect of diazoxide, a drug with multiple sites of action, including K+ channel activation, suggesting that diazoxide-induced membrane depolarization is not associated with activation of KATP channels, at least in this cell type (19). Moreover, in isolated liver mitochondria, other K+ channel openers, including aprikalim and nicorandil, were without effect on membrane potential, although in the same preparation, RP-66471, a more recently developed KATP channel opener, induced mitochondrial depolarization (61).

Here, in cardiac mitochondria, a KATP channel-mediated regulation of mitochondrial membrane potential is supported by three lines of evidence. First, structurally distinct K+ channel openers were effective in depolarizing mitochondria. Second, the effect of K+ channel openers on mitochondrial membrane potential was dependent on the electrochemical gradient for K+. Third, 5-HD, a selective KATP channel blocker (51), did not affect membrane potential by itself but prevented the depolarizing action of a K+ channel opener. Our findings are in accord with the property of cromakalim and other K+ channel openers to induce K+ flux through mitochondrial KATP channels (18). Under the present experimental condition (110 mM extramitochondrial K+ and Delta Psi  = -180 mV), opening of KATP channels is expected to lead to K+ influx and depolarization of mitochondria. In turn, a decrease in membrane potential would dissipate the driving force for ATP synthesis, triggering a compensatory activation of the mitochondrial respiratory chain. It has previously been shown that increase in the K+ permeability by valinomycin of the inner membrane decreases the rate of ATP synthesis and promotes respiration (53). The present study extends this concept and shows that activation of KATP channels not only induces membrane depolarization but can also reduce the rate of ATP synthesis and increase O2 consumption in cardiac mitochondria.

In addition to energy production, mitochondria have the capacity to store Ca2+, a function critical in the maintenance of cellular Ca2+ homeostasis (13). In the present study, isolated cardiac mitochondria, when challenged with repeated Ca2+ pulses, displayed the property to accumulate and store Ca2+. Opening of mitochondrial KATP channels rapidly released Ca2+ from preloaded mitochondria, an effect also seen with K+ ionophores. Although the precise mechanism for such an effect on Ca2+ release is unknown, the sensitivity toward KATP channel blockade and the dependence on extramitochondrial K+ concentration are in line with a KATP channel-mediated membrane depolarization and promotion of Ca2+ release. Such interpretation also concurs with the notion that setting the mitochondrial membrane potential is critical for cyclic accumulation and release of Ca2+ (30).

In the present study we further demonstrated that opening of mitochondrial KATP channels increased matrix volume, which is manifested through mitochondrial swelling. This finding supports previous reports that mitochondrial KATP channels can regulate the osmotic status of the mitochondrial matrix (15, 16). Depending on the extent of swelling, an increase in matrix volume may also lead to a change in the permeability of the outer membrane to macromolecules that are located within the intermembrane (47, 58). In this regard, the present observation, that opening of K+ channels could induce release of intermembrane proteins, is suggestive of a significant increase in matrix volume and of a possible compromise in the integrity of the mitochondrial membrane.

In summary, the present study provides direct evidence that opening of mitochondrial KATP channels modulates essential functions of isolated cardiac mitochondria. The cellular consequences of mitochondrial KATP channel opening are not known. It has been proposed that this ion conductance may participate in the protection of cardiac muscle from ischemia-reperfusion injury (17). Because mitochondrial Ca2+ overload is implicated in cellular injury (13), our findings may suggest a possible beneficial effect of mitochondrial KATP channel opening through regulation of mitochondrial Ca2+ levels. The present study also identifies a KATP channel-mediated decrease in the rate of ATP synthesis and a release of mitochondrial proteins. Because a decrease in cellular ATP content coupled with the presence of cytochrome c within the cytosol has been associated with cellular apoptosis (48, 56), this further suggests that opening of mitochondrial KATP channels may participate in the regulation of cellular viability. The net effect of opening of mitochondrial KATP channels is, however, difficult to predict in view of the diversity in cellular protective mechanisms (20, 21, 34, 35, 44, 57) and the complex nature of KATP channel gating (2, 4, 16, 36, 65). Indeed, it is still controversial whether in excitable tissues opening of K+ channels leads to programmed cell death (68) or promotes cellular survival (17, 20, 41).

    ACKNOWLEDGEMENTS

This research was supported by National Heart, Lung, and Blood Institute Grant HL-0711-22, a Merck Sharp & Dohme International Award in Clinical Pharmacology, and grants from the American Heart Association, the Miami Heart Research Institute, and the Bruce and Ruth Rappaport Program in Vascular Biology and Gene Delivery.

    FOOTNOTES

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.

Address for reprint requests: A. Terzic, Div. of Cardiovascular Diseases, Dept. of Medicine, Guggenheim-7F, Mayo Clinic and Foundation, Rochester, MN 55905.

Received 23 April 1998; accepted in final form 2 July 1998.

    REFERENCES
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

1.   Aguilar-Bryan, L., J. P. Clement, G. Gonzales, K. Kunjilwar, A. Babenko, and J. Bryan. Toward understanding the assembly and structure of KATP channels. Physiol. Rev. 78: 227-245, 1998[Abstract/Free Full Text].

2.   Alekseev, A. E., P. A. Brady, and A. Terzic. Ligand-insensitive state of cardiac ATP-sensitive K+ channels. Basis for channel opening. J. Gen. Physiol. 111: 381-394, 1998[Abstract/Free Full Text].

3.   Belyaeva, E. A., A. Szewczyk, B. Mikolajek, M. J. Nalecz, and L. Wojtczak. Demonstration of glibenclamide-sensitive K+ fluxes in rat liver mitochondria. Biochem. Mol. Biol. Int. 31: 493-500, 1993[Medline].

4.   Brady, P. A., A. E. Alekseev, and A. Terzic. Operative condition-dependent response of cardiac ATP-sensitive K+ channels toward sulfonylureas. Circ. Res. 82: 272-278, 1998[Abstract/Free Full Text].

5.   Brady, P. A., S. Zhang, J. R. Lopez, A. Jovanovic, A. E. Aleeksev, and A. Terzic. Dual effect of glyburide, an antagonist of KATP channels, on metabolic inhibition-induced Ca2+ loading in cardiomyocytes. Eur. J. Pharmacol. 308: 343-349, 1996[Medline].

6.   Brierley, G. P. The uptake and extrusion of monovalent cations by isolated heart mitochondria. Mol. Cell. Biochem. 10: 41-62, 1976[Medline].

7.   Chance, B., and G. R. Williamson. The respiratory chain and phosphorylation. Adv. Enzyme Regul. 17: 65-134, 1955.

8.   Diwan, J. J. Mitochondrial transport of K+ and Mg2+. Biochim. Biophys. Acta 895: 155-165, 1987[Medline].

9.   Dzeja, P. P., R. J. Zeleznikar, and N. D. Goldberg. Suppression of creatine kinase-catalyzed phosphotransfer results in increased phosphoryl transfer by adenylate kinase in intact skeletal muscle. J. Biol. Chem. 271: 12847-12851, 1996[Abstract/Free Full Text].

10.   Elvir-Mairena, J. R., A. Jovanovic, L. A. Gomez, A. E. Alekseev, and A. Terzic. Reversal of the ATP-liganded state of ATP-sensitive K+ channels by adenylate kinase activity. J. Biol. Chem. 271: 31903-31908, 1996[Abstract/Free Full Text].

11.   Evtodienko, Y. V., V. P. Zinchenko, E. L. Holmuhamedov, A. V. Gylkhandanyan, and A. M. Zhabotinsky. The stoichiometry of ion fluxes in oscillating mitochondria. Biochim. Biophys. Acta 589: 157-161, 1980[Medline].

12.   Ferrari, R. The role of mitochondria in ischemic heart disease. J. Cardiovasc. Pharmacol. 28: S1-S10, 1996.

13.   Ferrari, R., P. Pedersini, M. Bongrazio, G. Gaia, P. Bernocchi, F. Di Lisa, and O. Visioli. Mitochondrial energy production and cation control in myocardial ischemia and reperfusion. Basic Res. Cardiol. 88: 495-512, 1993[Medline].

14.   Findlay, I. Interactive regulation of the ATP-sensitive potassium channel of cardiac muscle. J. Cardiovasc. Pharmacol. 24: S6-S11, 1994.

15.   Garlid, K. D. Cation transport in mitochondria. Biochim. Biophys. Acta 1275: 123-126, 1996[Medline].

16.   Garlid, K. D. Physiology of mitochondria. In: Cell Physiology. Source Book, edited by N. Sperelakis. New York: Academic, 1998, p. 111-118.

17.   Garlid, K. D., P. Paucek, V. Yarov-Yarovoy, H. N. Murray, R. B. Darbenzio, A. J. D'Alonzo, N. J. Lodge, M. A. Smith, and G. J. Grover. Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Circ. Res. 81: 1072-1082, 1997[Abstract/Free Full Text].

18.   Garlid, K. D., P. Paucek, V. Yarov-Yarovoy, X. Sun, and P. Schindler. The mitochondrial KATP channel as a receptor for potassium channel openers. J. Biol. Chem. 271: 8796-8799, 1996[Abstract/Free Full Text].

19.   Grimmsmann, T., and I. Rustenbeck. Direct effect of diazoxide on mitochondria in pancreatic B-cells and on isolated liver mitochondria. Br. J. Pharmacol. 123: 781-788, 1998[Medline].

20.   Gross, G. J. ATP-sensitive potassium channels and myocardial preconditioning. Basic Res. Cardiol. 90: 85-88, 1995[Medline].

21.   Grover, G. J. Pharmacology of ATP-sensitive potassium channel (KATP) openers in models of myocardial ischemia and reperfusion. Can. J. Physiol. Pharmacol. 75: 309-315, 1997[Medline].

22.   Gunter, T. E., K. K. Gunter, S. Sheu, and C. E. Gavin. Mitochondrial calcium transport: physiological and pathological relevance. Am. J. Physiol. 267 (Cell Physiol. 36): C313-C339, 1994[Abstract/Free Full Text].

23.   Halestrap, A. P. Regulation of mitochondrial metabolism through changes in matrix volume. Biochem. Soc. Trans. 22: 522-529, 1994[Medline].

24.   Halestrap, A. P. The regulation of the matrix volume mammalian mitochondria in vitro and its role in control of mitochondrial metabolism. Biochim. Biophys. Acta 973: 355-382, 1979.

25.   Holmuhamedov, E. L. Oscillating dissipative structures in mitochondrial suspension. Eur. J. Biochem. 158: 543-546, 1986[Medline].

26.   Holmuhamedov, E. L., E. A. Chukhlova, V. V. Teplova, V. P. Zinchenko, and Y. V. Evtodienko. Excitability of inner mitochondrial membrane. Irreversible increase in mitochondrial membrane K+ permeability by divalent cations. Biol. Membr. 5: 866-872, 1988.

27.   Holmuhamedov, E. L., V. V. Teplova, E. A. Chukhluva, Y. V. Evtodienko, and R. G. Urlich. Strontium excitability of the inner mitochondrial membrane: regenerative strontium-induced strontium release. Biochem. Mol. Biol. Int. 36: 39-49, 1995[Medline].

28.   Ichas, F., L. S. Jouaville, S. S. Sidash, J. P. Mazat, and E. L. Holmuhamedov. Mitochondrial calcium spiking: a transduction mechanism based on calcium-induced permeability transition involved in cell calcium signalling. FEBS Lett. 348: 211-215, 1994[Medline].

29.   Inoue, I., H. Nagase, K. Kishi, and T. Higuti. ATP-sensitive K+ channel in the mitochondrial inner membrane. Nature 352: 244-247, 1991[Medline].

30.   Jouaville, L. S., F. Ichas, E. L. Holmuhamedov, P. Camacho, and J. D. Lechleiter. Synchronization of calcium waves by mitochondrial substrates in Xenopus laevis oocytes. Nature 377: 438-441, 1995[Medline].

31.   Jovanovic, A., A. E. Alekseev, and A. Terzic. Intracellular diadenosine polyphosphates: a novel family of inhibitory ligands of the ATP-sensitive K+ channel. Biochem. Pharmacol. 54: 219-225, 1997[Medline].

32.   Jovanovic, A., S. Jovanovic, E. Lorenz, and A. Terzic. Recombinant cardiac ATP-sensitive K+ channel subunits confer resistance towards chemical hypoxia-reoxygenation injury. Circulation 98: 1548-1555, 1998[Abstract/Free Full Text].

33.   Jovanovic, A., S. Jovanovic, D. C. Mays, J. J. Lipsky, and A. Terzic. Diadenosine 5',5''-P1,P5-pentaphosphate harbors the properties of a signaling molecule in the heart. FEBS Lett. 423: 314-318, 1998[Medline].

34.   Jovanovic, A., J. R. Lopez, A. E. Alekseev, W. K. Shen, and A. Terzic. Adenosine prevents K+-induced Ca2+ loading: insight into cardioprotection during cardioplegia. Ann. Thorac. Surg. 65: 586-591, 1998[Abstract/Free Full Text].

35.   Jovanovic, A., J. R. Lopez, and A. Terzic. Cytosolic Ca2+ domain-dependent protective action of adenosine in cardiomyocytes. Eur. J. Pharmacol. 298: 63-69, 1996[Medline].

36.   Jovanovic, A., S. Zhang, A. E. Alekseev, and A. Terzic. Diadenosine polyphosphate-induced inhibition of cardiac KATP channels: operative state-dependent regulation by a nucleoside diphosphate. Pflügers Arch. 431: 800-802, 1996[Medline].

37.   Jung, D. W., E. Chavez, and G. P. Brierley. Energy-dependent exchange of K+ in heart mitochondria. Arch. Biochem. Biophys. 183: 452-459, 1977[Medline].

38.   Kamo, N., M. Muratsugu, R. Hongoh, and Y. Kobatake. Membrane potential measured with an electrode sensitive to tetraphenyl phosphonium and relationship between proton electrochemical potential and phosphorylation potential in steady state. J. Membr. Biol. 49: 105-121, 1979[Medline].

39.   Kluck, R. M., E. Bossy-Wetzel, D. R. Green, and D. D. Newmayer. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275: 1132-1136, 1997[Abstract/Free Full Text].

40.   Krause, S. M., and W. E. Jacobus. Specific enhancement of the cardiac myofibrillar ATPase by bound creatine kinase. J. Biol. Chem. 267: 2480-2486, 1992[Abstract/Free Full Text].

41.   Lauritzen, I., J. R. De Weille, and M. Lazdunski. The potassium channel opener (-)-cromakalim prevents glutamate-induced cell death in hippocampal neurons. J. Neurochem. 69: 1570-1579, 1997[Medline].

42.   Lazdunski, M. ATP-sensitive potassium channels: an overview. J. Cardiovasc. Pharmacol. 24: S1-S5, 1994.

43.   Lesnefsky, E. J., B. Tandler, J. Ye, T. J. Slabe, J. Turkaly, and C. L. Hoppel. Myocardial ischemia decreases oxidative phosphorylation through cytochrome oxidase in subsarcolemmal mitochondria. Am. J. Physiol. 273 (Heart Circ. Physiol. 42): H1544-H1554, 1997[Abstract/Free Full Text].

44.   Lopez, J. R., R. A. Ghanbari, and A. Terzic. A KATP channel opener protects cardiomyocytes from Ca2+ waves: a laser confocal microscopy study. Am. J. Physiol. 270 (Heart Circ. Physiol. 39): H1384-H1389, 1996[Abstract/Free Full Text].

45.   Lopez, J. R., A. Jovanovic, and A. Terzic. Spontaneous calcium waves without contraction in cardiac myocytes. Biochem. Biophys. Res. Commun. 214: 781-787, 1995[Medline].

46.   Lorenz, E., A. E. Alekseev, G. B. Krapivinsky, A. J. Carrasco, D. E. Clapham, and A. Terzic. Evidence for direct physical association between a K+ channel (Kir6.2) and an ABC protein (SUR1) which affects cellular distribution and kinetic behavior of an ATP-sensitive K+ channel. Mol. Cell. Biol. 18: 1652-1659, 1998[Abstract/Free Full Text].

47.   MacLennan, D. H., G. Lenaz, and L. Szarkovska. Studies on the mechanism of oxidative phosphorylation. IX. Effect of cytochrome c on energy-linked processes. J. Biol. Chem. 241: 5251-5259, 1996[Abstract/Free Full Text].

48.   Marton, A., R. Mihalik, A. Bratincsak, V. Adleff, I. Petak, M. Vegh, P. I. Bauer, and P. Krajcsi. Apoptotic cell death induced by inhibitors of energy conservation. Eur. J. Biochem. 250: 467-475, 1997[Medline].

49.   Murutsagu, M., N. Kamo, K. Kurihaara, and Y. Kobatake. Selective electrode for dibenzyl dimethyl ammonium cation as indicator of the membrane potential in biological systems. Biochim. Biophys. Acta 464: 613-619, 1977[Medline].

50.   Noma, A. ATP-regulated K+ channels in cardiac muscle. Nature 305: 147-148, 1983[Medline].

51.   Notsu, T., I. Tanaka, M. Takano, and A. Noma. Blockade of the ATP-sensitive K+ channel by 5-hydroxydecanoate in guinea pig ventricular myocytes. J. Pharmacol. Exp. Ther. 260: 702-708, 1992[Abstract/Free Full Text].

52.   Paucek, P., G. D. Mironova, F. Mahdi, A. D. Beavis, G. Woldergiorgis, and K. D. Garlid. Reconstitution and partial purification of the glybenclamide-sensitive, ATP-dependent K+ channel from rat liver and beef heart mitochondria. J. Biol. Chem. 267: 26062-26069, 1992[Abstract/Free Full Text].

53.   Petronili, V., D. Pietrobon, M. Zoratti, and G. F. Azzone. Free energy coupling between H+-generating and H+-consuming pumps. Eur. J. Biochem. 155: 423-431, 1986[Medline].

54.   Quast, U., and N. S. Cook. Moving together: K+ channel openers and ATP-sensitive K+ channels. Trends Pharmacol. Sci. 10: 431-434, 1989[Medline].

55.   Rauch, U., K. Schulze, B. Witzenbichler, and H. P. Schulthesiss. Alteration of the cytosolic-mitochondrial distribution of high-energy phosphates during global myocardial ischemia contributes to early contractile failure. Circ. Res. 75: 760-769, 1994[Abstract/Free Full Text].

56.   Reed, J. C. Cytochrome c: can't live with it---can't live without it. Cell 91: 559-562, 1997[Medline].

57.   Romashko, D. N., E. Marban, and B. O'Rourke. Subcellular metabolic transients and mitochondrial redox waves in heart cells. Proc. Natl. Acad. Sci. USA 95: 1618-1623, 1998[Abstract/Free Full Text].

58.   Schnaitman, C., and J. W. Greenawalt. Enzymatic properties of the inner and outer membranes of rat liver mitochondria. J. Cell Biol. 38: 158-175, 1968[Abstract/Free Full Text].

59.   Seino, S., N. Inagaki, N. Namba, and T. Gonoi. Molecular biology of the beta -cell ATP-sensitive K+ channel. Diabetes Rev. 4: 177-190, 1996.

60.   Suzuki, M., K. Kotake, K. Fujikura, N. Inagaki, T. Suzuki, T. Gonoi, S. Seino, and K. Takata. Kir6.1. A possible subunit of ATP-sensitive K+ channels in mitochondria. Biochem. Biophys. Res. Commun. 241: 693-697, 1997[Medline].

61.   Szewczyk, A. Intracellular targets for antidiabetic sulfonylureas and potassium channel openers. Biochem. Pharmacol. 54: 961-965, 1997[Medline].

62.   Szewczyk, A., A. Czyz, G. Wojcik, L. Wojczak, and M. Nalecz. ATP-regulated K+ channel in mitochondria: pharmacology and function. J. Bioenerg. Biomembr. 28: 147-152, 1996[Medline].

63.   Szewczyk, A., G. Wojcik, N. A. Lobanov, and M. J. Nalecz. The mitochondrial sulfonylurea receptor: identification and characterization. Biochem. Biophys. Res. Commun. 230: 611-615, 1997[Medline].

64.   Szewczyk, A., G. Wojcik, and M. Nalecz. Potassium channel opener, RP 66471, induces membrane depolarization of rat liver mitochondria. Biochem. Biophys. Res. Commun. 207: 126-132, 1995[Medline].

65.   Terzic, A., I. Findlay, Y. Hosoya, and Y. Kurachi. Dualistic behavior of ATP-dependent K+ channel towards intracellular nucleoside diphosphates. Neuron 12: 1049-1058, 1994[Medline].

66.   Terzic, A., A. Jahangir, and Y. Kurachi. Cardiac ATP-sensitive K+ channel regulation by intracellular nucleotides and K+channel opening drugs. Am. J. Physiol. 269 (Cell Physiol. 38): C525-C545, 1995[Abstract/Free Full Text].

67.   Terzic, A., R. T. Tung, and Y. Kurachi. Nucleotide regulation of ATP sensitive potassium channels. Cardiovasc. Res. 28: 746-753, 1996.

68.   Yu, S. P., C. H. Yeh, S. L. Sensi, B. J. Gwag, L. M. T. Canzoniero, Z. S. Fahrangrazi, H. S. Ying, M. Tian, L. l. Dugan, and D. W. Choi. Mediation of neuronal apoptosis by enhancement of outward potassium current. Science 278: 114-117, 1997[Abstract/Free Full Text].


Am J Physiol Heart Circ Physiol 275(5):H1567-H1576
0002-9513/98 $5.00 Copyright © 1998 the American Physiological Society




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Holmuhamedov, E. L.
Right arrow Articles by Terzic, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Holmuhamedov, E. L.
Right arrow Articles by Terzic, A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online